Zacks Research Upgrades Itron (NASDAQ:ITRI) to Hold

Itron (NASDAQ:ITRI) was upgraded by equities researchers at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Thursday,Zacks.com reports.

ITRI has been the subject of a number of other reports. Oppenheimer increased their target price on Itron from $125.00 to $133.00 and gave the company an “outperform” rating in a research report on Wednesday, February 18th. Johnson Rice raised shares of Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price target on the stock in a research note on Monday, January 5th. Stephens upgraded shares of Itron from an “equal weight” rating to an “overweight” rating and set a $130.00 price objective for the company in a research report on Monday, November 3rd. Wall Street Zen downgraded shares of Itron from a “buy” rating to a “hold” rating in a report on Wednesday, January 14th. Finally, Robert W. Baird set a $128.00 target price on shares of Itron and gave the company an “outperform” rating in a research report on Wednesday, February 18th. Seven analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $138.56.

Itron Trading Down 2.2%

Shares of Itron stock opened at $93.95 on Thursday. The firm has a market cap of $4.22 billion, a price-to-earnings ratio of 14.43, a PEG ratio of 0.84 and a beta of 1.48. The business has a 50-day moving average price of $97.80 and a 200-day moving average price of $109.14. The company has a quick ratio of 1.56, a current ratio of 1.80 and a debt-to-equity ratio of 0.45. Itron has a twelve month low of $88.57 and a twelve month high of $142.00.

Itron (NASDAQ:ITRI) last posted its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 EPS for the quarter, topping analysts’ consensus estimates of $2.19 by $0.27. Itron had a return on equity of 20.04% and a net margin of 12.72%.The company had revenue of $571.66 million for the quarter, compared to the consensus estimate of $561.31 million. During the same period in the previous year, the business earned $1.35 earnings per share. The firm’s revenue for the quarter was down 6.7% on a year-over-year basis. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. Equities research analysts anticipate that Itron will post 5.33 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, SVP Christopher E. Ware sold 763 shares of the firm’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $100.17, for a total value of $76,429.71. Following the completion of the sale, the senior vice president owned 31,043 shares in the company, valued at approximately $3,109,577.31. This trade represents a 2.40% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Donald L. Reeves III sold 519 shares of Itron stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $97.84, for a total transaction of $50,778.96. Following the transaction, the senior vice president directly owned 29,951 shares of the company’s stock, valued at approximately $2,930,405.84. This represents a 1.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 47,647 shares of company stock valued at $4,746,590. 1.45% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Private Trust Co. NA raised its holdings in shares of Itron by 112.4% in the fourth quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock worth $25,000 after buying an additional 145 shares during the period. Twin Peaks Wealth Advisors LLC purchased a new position in Itron during the 2nd quarter valued at $30,000. Employees Retirement System of Texas bought a new position in Itron in the 3rd quarter valued at $32,000. Bessemer Group Inc. grew its position in Itron by 125.7% in the 2nd quarter. Bessemer Group Inc. now owns 255 shares of the scientific and technical instruments company’s stock valued at $34,000 after acquiring an additional 142 shares during the last quarter. Finally, Optiver Holding B.V. purchased a new stake in Itron in the third quarter worth $36,000. Institutional investors own 96.19% of the company’s stock.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.